Reach Us +441234923305


Chittaranjan Das | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Chittaranjan Das

Department of Chemistry, Purdue University, USA


Chitta Das is an Associate Professor in the Department of Chemistry at Purdue University. He received his Ph.D. from the Indian Institute of Science, Bangalore (India). Following his PhD education, he became a post-doc in Dr. Greg Petsko's group at Harvard Medical School and Brandeis University. He uses X-ray crystallography to study structure-function relationship of bacterial effectors that regulate ubiquitin signaling.

Should Deubiquitinating Enzymes be Targeted for Therapy?

Effective, non-toxic therapies for many diseases, including malignancies, metabolic syndromes and age-dependent neurodegeneration remain elusive, though not for lack of effort from scientists all over the world.... Read More»

Sokol V Todi and Chittaranjan Das

Editorial: Clin Pharmacol Biopharm 2012, 1:e108

DOI: 10.4172/2167-065X.1000e108

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF